The Bronchitol study appears to have gone well. What happens now? I am new to the process and just trying to understand.
It looks like the company has applied to market the drug in europe, but I'm not sure what that means for availability in the US.
Here is a link to the company media release.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.pharmaxis.com.au/news/nc/Home/n/pharmaxis-announces-sustained-benefit-with-bronchitol-in-phase-3-cystic-fibrosis-trial-091202">http://www.pharmaxis.com.au/ne...-fibrosis-trial-091202</a>
It looks like the company has applied to market the drug in europe, but I'm not sure what that means for availability in the US.
Here is a link to the company media release.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.pharmaxis.com.au/news/nc/Home/n/pharmaxis-announces-sustained-benefit-with-bronchitol-in-phase-3-cystic-fibrosis-trial-091202">http://www.pharmaxis.com.au/ne...-fibrosis-trial-091202</a>